Replimune Group, Inc. (REPL)

Replimune Group Income Statement

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Selling, General & Admin	63.89	60.72	50.97	39.18	23.55	17.44
Research & Development	175.27	172.13	123.19	75.97	53.6	35.68
Operating Expenses	239.16	232.85	174.17	115.14	77.15	53.11
Operating Income	-239.16	-232.85	-174.17	-115.14	-77.15	-53.11
Interest Expense	-7.86	-6.66	-4.16	-2.22	-3.06	-1.92
Interest & Investment Income	20.68	23.36	10.01	0.39	0.92	2.42
Currency Exchange Gain (Loss)	-1.39	0.77	-5.68	-1.1	-0.7	-0.02
Other Non Operating Income (Expenses)	-	-	-	0.04	0.04	-
EBT Excluding Unusual Items	-227.73	-215.39	-174	-118.04	-79.96	-52.63
Other Unusual Items	-	-	-	-	-0.91	-
Pretax Income	-227.73	-215.39	-174	-118.04	-80.87	-52.63
Income Tax Expense	0.51	0.41	0.29	-	-	-
Net Income	-228.24	-215.79	-174.28	-118.04	-80.87	-52.63
Net Income to Common	-228.24	-215.79	-174.28	-118.04	-80.87	-52.63
Shares Outstanding (Basic)	77	67	58	52	46	34
Shares Outstanding (Diluted)	77	67	58	52	46	34
Shares Change (YoY)	15.98%	14.36%	11.49%	12.89%	34.99%	47.69%
EPS (Basic)	-2.96	-3.24	-2.99	-2.26	-1.75	-1.54
EPS (Diluted)	-2.96	-3.24	-2.99	-2.26	-1.75	-1.54
Free Cash Flow	-191.98	-191.13	-130.32	-84.52	-63.78	-67.09
Free Cash Flow Per Share	-2.49	-2.87	-2.24	-1.62	-1.38	-1.96
EBITDA	-236.21	-230.2	-171.72	-113	-75.44	-52.58
D&A For EBITDA	2.96	2.66	2.45	2.15	1.71	0.53
EBIT	-239.16	-232.85	-174.17	-115.14	-77.15	-53.11

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q